NCT04515628View on ClinicalTrials.gov

Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 2, 2020

Primary Completion Date

October 18, 2020

Study Completion Date

October 26, 2020

Conditions
Healthy Participants
Interventions
DRUG

Rosuvastatin

Specified dose on specified days

DRUG

Branebrutinib

Specified dose on specified days

Trial Locations (1)

84124

ICON (LPRA) - Salt Lake, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04515628 - Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants | Biotech Hunter | Biotech Hunter